Table 1.

Comparison of published cases of VZV-vasculitis-related chorea and our patient showing diverse presentations, different diagnostic measures, methods of treatment and its effects. The table has been arranged chronologically, in order of publication date

no.	Authors	Age, sex	Affected side	Time from VZV infection to hemichorea	Varicella vaccination status	Other clinical manifestations	Lesion location (MRI)	Affected vessels (MRA)	Side of described lesions	Laboratory findings - serum	Laboratory findings - CSF	Treatment	Clinical recovery time
1	Klaus P Hammann et al. [15]	20, F	R	2 weeks	not available (N/A)	myoclonic-like movements of arm and face paraesthesiae of fingers motor aphasia pyramidal syndrome	N/A	N/A	N/A	(+) anti-VZV IgG	low protein content	carbamazepine	N/A
2	Silerstein et al.[16]	6	R	2–3 months	N/A	facial weakness hemiparesis	globus pallidus caudate nucleus frontal lobe	ICA ACA (A1) MCA (M1)	L	(-) anti-VZV IgG	9 white blood cells/mm3	glucocorticoids	N/A
3	Miravet et al.[17]	4	N/A	N/A	N/A	transient hemifacial weakness	basal ganglia white matter	MCA	N/A	N/A	N/A	N/A	N/A
4	Miravet et al.[17]	5	L	N/A	N/A	hemiparesis	basal ganglia	MCA ACA	N/A	N/A	N/A	N/A	N/A
5	Buompadre et al.[18]	4, F	N/A	N/A	N/A	hemiparesis	lentiform nucleus caudate nucleus internal capsule	MCA (M1)	N/A	N/A	N/A	N/A	N/A
6	Bartolini et al.[19]	3, M	R	15 days	N/A	none	caudate nucleus lenticular nucleus	MCA	L	(+) IgG and IgM Ab against VZV (+) anti-protein S IgG and IgM antibodies	N/A	ASA	N/A
7	Bartolini et al.[19]	4, F	R	7 months	N/A	none	caudate nucleus lenticular nucleus internal capsule	ACA (A1) MCA (M1)	L + R	(+) IgG Ab against VZV (-) IgM Ab against VZV	N/A	ASA valproic acid	N/A
8	Bauder et al.[20]	6,F	N/A	N/A	N/A	headache	N/A	MCA PCA	N/A	N/A	(+) VZV-DNA PCR	acyclovir glucocorticoids	N/A
9	Hackenberg et al.[21]	4, M	N/A	N/A	N/A	gait disorder dysphasia facial weakness mood disorder	putamen	ICA MCA ACA	R	N/A	(-) VZV-DNA PCR	acyclovir ASA glucocorticoids cyclophosphamide	N/A
10	Bulder et al. [22]	2, M	R	2 months	N/A	none	caudate nucleus putamen	ICA ACA MCA (M1-M3)	L	N/A	(-) VZV-DNA PCR	ASA	1 month
11	Bulder et al. [22]	3, F	L	7 months	N/A	none	caudate nucleus putamen	MCA ACA	R	N/A	N/A	ASA	3 weeks
12	Spagnoli et al. [23]	5, F	L	5 months	unvaccinated	trigeminal autonomic pain vomiting hemifacial grimaces lingual dyskinesias hypotonia hyposthenia exaggerated knee reflex	lentiform nucleus internal capsule caudate nucleus	ACA (A1)	R	(+) IgG Ab against VZV	N/A	acyclovir ASA valproic acid	N/A
13	Davico et al.[24]	3, M	R	6 months	N/A	none	lentiform nucleus internal capsule	none	L	(+) anti-VZV IgG	N/A	ASA prednisone haloperidol	3 weeks
14	Davico et al.[24]	3, M	L	4 months	N/A	none	thalamus internal capsule	ICA MCA	R	(+) anti-VZV IgG	N/A	ASA prednisone haloperidol	3 weeks
15	Helmuth et al.[25]	4, M	R	8 months	N/A	hemiparesis	basal ganglia	none	L	N/A	(+) VZV-DNA PCR (+) IgG Ab against VZV	acyclovir ASA glucocorticoids	N/A
16	Helmuth et al.[25]	5, M	R	6 months	N/A	dysarthria	temporal lobe	ICA	L	N/A	(+) VZV-DNA PCR (+) IgG Ab against VZV	acyclovir ASA glucocorticoids	N/A
17	Helmuth et al.[25]	5, M	L	4 months	N/A	hemiparesis	white matter	MCA ACA ICA	R	N/A	(+) VZV-DNA PCR (-) IgG Ab against VZV	acyclovir ASA	N/A
18	Elbishari et al.[26]	1, M	N/A	5 months	N/A	upper extremity monoparesis intermittent ataxia	globus pallidus	MCA ACA	L	N/A	(-) VZV-DNA PCR	N/A	N/A
19	Bertamino et al.[27]	6, F	R	7 months	unvaccinated	none	thalamus	none	L	(+) IgG Ab against VZV	(+) IgG Ab against VZV (-) VZV-DNA PCR	acyclovir ASA methylprednisolone	N/A
20	O’Reilly et al. [28]	1, M	N/A	5 months	unvaccinated	upper extremity monoparesis ataxia	globus pallidus	MCA ACA	L	N/A	(+) VZV-DNA PCR	acyclovir ASA methylprednisolone	N/A
21	Bertanimo et al. [29]	5, F	N/A	9 months	unvaccinated	none	basal ganglia	none	N/A	N/A	(+) IgG Ab against VZV (-) VZV-DNA PCR low protein content	acyclovir ASA glucocorticoids	N/A
22	Bertanimo et al. [29]	4, M	N/A	8 months	unvaccinated	none	frontal lobe basal ganglia	ICA MCA (M1) ACA (A1)	R	N/A	(+) VZV-DNA PCR	acyclovir ASA prednisone	N/A
23	Schwidetzky et al. [30]	6,F	L	4 months	N/A	hemiparesis	N/A	MCA (M1)	R	N/A	(+) VZV-DNA PCR (+) IgG Ab against VZV	acyclovir methylprednisolone	N/A
24	Our patient	8, M	R	6 months	Unvaccinated	headaches transient facial weakness slurred speech tongue deviation	putamen internal capsule subcortical white matter	none	L	(+) IgG Ab against VZV marginally negative IgM Ab against VZV	(+) VZV-DNA PCR	acyclovir ASA glucocorticoids	2 weeks